The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Optimizing pancreatic cancer management with next generation imaging and liquid biopsy (CHANGE-PDAC).
 
Erica S Tsang
No Relationships to Disclose
 
Eric Andrew Collisson
Stock and Other Ownership Interests - BloodQ; Clara Health; Guardant Health; Hint Health; Tatara Therapeutics
Consulting or Advisory Role - Merck
Research Funding - AstraZeneca (Inst); Ferro Oncology/Bridge Bio (Inst); Loxo/Bayer (Inst); Merck KGaA (Inst)
Expert Testimony - NantBioScience
 
Zhen J. Wang
Stock and Other Ownership Interests - Nextrast
 
Sorbarikor Piawah
No Relationships to Disclose
 
Taylor Sanchez
No Relationships to Disclose
 
Margaret A. Tempero
Consulting or Advisory Role - Abbvie; Advance Medical/Teladoc Health; AstraZeneca; Bristol-Myers Squibb; EcoR1 Capital; Eisai; Elicio Therapeutics; FibroGen; GlaxoSmithKline; Immunovia; Ipsen; Karyopharm Therapeutics; Merck; Pharmacyclics; Swedish Orphan Biovitrum
Research Funding - Celgene (Inst); Halozyme (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; BIOPHARM; Bristol-Myers Squibb; Eisai; GlaxoSmithKline; Merck; Pharmacyclics; Pharmacyte Biotech; Tocagen
 
Andrew H. Ko
Honoraria - BioAscent; Clinical Care Options; Medscape; PER; PlatformQ Health; Research to Practice
Consulting or Advisory Role - ERYTECH Pharma; Five Prime Therapeutics; Gritstone Bio; Imugene; Ipsen; Roche/Genentech; Signatera; SynCoreBio; Syros Pharmaceuticals; Turning Point Therapeutics; Tyme
Speakers' Bureau - Clinical Care Options
Research Funding - AbGenomics International (Inst); Apexigen (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); Leap Therapeutics (Inst); Merck (Inst)